ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in GILD — Gilead Sciences, Inc.
CIK 1164508
BOSTON, MA
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$121,274,271
+$32,754,183 QoQ
Shares Held
959,904
+33.1% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#124
of 2,258 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. GILD ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
959,904 | $121,274,271 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,274,271 | 959,904 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $88,520,088 | 721,200 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $73,110,816 | 658,656 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $47,295,368 | 426,584 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $6,049,355 | 53,988 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $12,895,406 | 139,606 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $251,240,728 | 2,996,669 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $314,590,846 | 4,585,204 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $369,651,217 | 5,046,433 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $678,732,077 | 8,378,374 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $765,712,189 | 10,217,670 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $684,929,567 | 8,887,110 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $679,623,946 | 8,191,201 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $705,346,518 | 8,216,034 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $742,536,311 | 12,036,575 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $968,450,514 | 15,668,185 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,070,231,622 | 18,002,214 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $307,724,447 | 4,238,045 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,564,822 | 36,719 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $42,496,535 | 617,144 | Shares | Defined | 2021-08-13 | |
| 2020-12-31 | $179,568,797 | 3,082,197 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $134,779,341 | 2,132,922 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $152,375,207 | 1,980,442 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $82,189,424 | 1,099,377 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||